<VariationArchive VariationID="1076011" VariationName="NM_001029896.2(WDR45):c.938del (p.Gly313fs)" VariationType="Deletion" Accession="VCV001076011" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1065443" VariationID="1076011">
      <GeneList>
        <Gene Symbol="WDR45" FullName="WD repeat domain 45" GeneID="11152" HGNC_ID="HGNC:28912" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="49074442" stop="49101178" display_start="49074442" display_stop="49101178" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NW_025791820.1" start="233393" stop="260129" display_start="233393" display_stop="260129" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48932091" stop="48958058" display_start="48932091" display_stop="48958058" Strand="-" />
          </Location>
          <OMIM>300526</OMIM>
          <Haploinsufficiency last_evaluated="2015-04-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=WDR45">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-04-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=WDR45">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001029896.2(WDR45):c.938del (p.Gly313fs)</Name>
      <CanonicalSPDI>NC_000023.11:49075170:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="49075171" stop="49075171" display_start="49075171" display_stop="49075171" variantLength="1" positionVCF="49075170" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48932830" stop="48932830" display_start="48932830" display_stop="48932830" variantLength="1" positionVCF="48932829" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>G313fs</ProteinChange>
      <ProteinChange>G314fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.48932831del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.48932831del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.49075172del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.49075172del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033004.2" sequenceAccession="NG_033004" sequenceVersion="2" change="g.31000del">
            <Expression>NG_033004.2:g.31000del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001029896.2" sequenceAccession="NM_001029896" sequenceVersion="2" change="c.938del" MANESelect="true">
            <Expression>NM_001029896.2:c.938del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001025067.1" sequenceAccession="NP_001025067" sequenceVersion="1" change="p.Gly313fs">
            <Expression>NP_001025067.1:p.Gly313fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007075.4" sequenceAccession="NM_007075" sequenceVersion="4" change="c.941del">
            <Expression>NM_007075.4:c.941del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009006.2" sequenceAccession="NP_009006" sequenceVersion="2" change="p.Gly314fs">
            <Expression>NP_009006.2:p.Gly314fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2147814810" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001029896.2(WDR45):c.938del (p.Gly313fs) AND Neurodegeneration with brain iron accumulation 5" Accession="RCV001389746" Version="6">
        <ClassifiedConditionList TraitSetID="9501">
          <ClassifiedCondition DB="MedGen" ID="C3550973">Neurodegeneration with brain iron accumulation 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-08-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-08-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23176820</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27681470</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29171013</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29445477</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9501" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17735" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Beta-propeller protein-associated neurodegeneration</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD</ElementValue>
                <XRef Type="MIM" ID="300894" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neurodegeneration with brain iron accumulation 5</ElementValue>
                <XRef ID="MONDO:0010476" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA5</ElementValue>
                <XRef Type="MIM" ID="300894" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BPAN</ElementValue>
                <XRef Type="MIM" ID="300894" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SENDA</ElementValue>
                <XRef Type="MIM" ID="300894" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Beta-propeller protein-associated neurodegeneration (BPAN) is typically characterized by early-onset seizures, infantile-onset developmental delay, intellectual disability, absent-to-limited expressive language, motor dysfunction (ataxia), and abnormal behaviors often similar to autism spectrum disorder. Seizure types including generalized (absence, tonic, atonic, tonic-clonic and myoclonic), focal with impaired consciousness, and epileptic spasms, as well as epileptic syndromes (West syndrome and Lennox-Gastaut syndrome) can be seen. With age seizures tend to resolve or become less prominent, whereas cognitive decline and movement disorders (progressive parkinsonism and dystonia) emerge as characteristic findings.</Attribute>
                <XRef ID="NBK424403" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12570" />
                <XRef ID="12570" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28211668</ID>
                <ID Source="BookShelf">NBK424403</ID>
              </Citation>
              <XRef ID="329284" DB="Orphanet" />
              <XRef ID="C3550973" DB="MedGen" />
              <XRef ID="MONDO:0010476" DB="MONDO" />
              <XRef Type="MIM" ID="300894" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3116875" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11706649|MedGen:C3550973" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001591199" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23176820</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29445477</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29171013</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27681470</ID>
          </Citation>
          <Comment>This sequence change results in a premature translational stop signal in the WDR45 gene (p.Gly314Valfs*16). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 48 amino acids of the WDR45 protein. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the WDR45 protein. Other variant(s) that disrupt this region (p.Tyr336Cysfs*5) have been determined to be pathogenic (PMID: 23176820, 29445477, 29171013, 27681470). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has not been reported in the literature in individuals with WDR45-related conditions. This variant is not present in population databases (ExAC no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WDR45" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.48932830del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3550973" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3116875" TraitType="Disease" MappingType="XRef" MappingValue="C3550973" MappingRef="MedGen">
        <MedGen CUI="C3550973" Name="Neurodegeneration with brain iron accumulation 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

